Biomedical Engineering Reference
In-Depth Information
Abstract G-protein-coupled receptors (GPCRs) are a large superfamily of plasma
membrane proteins that play central roles in transducing endocrine, neural and
sensory signals. In humans, more than 30 disorders are associated with mutations
in GPCRs and these proteins are common drug development targets, with 30-50%
of drugs targeting them. GPCR mutants are frequently misfolded, recognized as
defective by the cellular quality control system, retained in the endoplasmic reticu-
lum and do not traffic to the plasma membrane. The use of small molecules chap-
erones (pharmacological chaperones or “pharmacoperones”) to rescue misfolded
GPCRs has provided a new approach for treatment of human diseases caused by
misfolding and misrouting. This chapter provides an overview of the molecular
basis of this approach using the human gonadotropin-releasing hormone receptor
(hGnRHR) as model for treatment of conformational diseases provoked by
misfolded GPCRs.
Keywords Gonadotropin-releasing hormone receptor ￿ G protein coupled receptor
￿ Misfolding ￿ Pharmacological chaperone ￿ Pharmacoperone
Abbreviations
ER
Endoplasmic reticulum
GnRH
Gonadotropin-releasing hormone
GPCR
G-protein coupled receptors
hGnRHR
Human gonadotropin-releasing hormone receptor
HH
Hypogonadotropic hypogonadism
HTS
High throughput screening
PM
Plasma membrane
QCS
Quality control system
tTA
Tetracycline-controlled transactivator
WT
Wild-type
14.1
Introduction
G-protein coupled receptors (GPCRs) constitute a large superfamily of cell surface
plasma membrane proteins that transduce signals from outside to inside of the cell
by coupling to heterotrimeric G-proteins (Dong et al. 2007 ; Ulloa-Aguirre and
Search WWH ::




Custom Search